The Middle East & Africa diabetes care devices market size is anticipated to reach USD 1.79 billion by 2030, growing at a CAGR of 8.20% from 2024 to 2030. The rapidly growing technological innovations and an increase in obesity prevalence primarily fuel the demand for diabetes care devices in the MEA. Furthermore, the increasing prevalence of diabetes, strategic initiatives such as collaborations and partnerships, and the rising use of insulin-delivery devices are boosting the market in the MEA. For instance, in December 2023, the International Diabetes Federation (IDF) and FIND joined to strengthen the expertise in continuous glucose monitoring (CGM) technology for healthcare professionals and diabetes patients. This partnership, known as ACCEDE (Improving CGM Access for Diabetes Equality), targets improving diabetes care through CGM usage in underprivileged nations, mainly focusing on Kenya and South Africa, which are low-income countries.
The growing awareness of diabetes care is driving the Middle East and Africa industry. With the rising prevalence of chronic diseases, the adoption of healthier lifestyles, and growing government initiatives, raises the demand, resulting in market expansion. For instance, in 2021, the UAE government has set a goal to improve its citizens' overall health and well-being, including reducing the prevalence of chronic diseases like diabetes. The National Agenda for UAE Vision 2021 includes strategies to enhance healthcare services, promote healthy lifestyles, and invest in research and innovation in the healthcare sector. These initiatives aim to reduce the burden of diabetes on the healthcare system and improve patients' overall quality of life.
This product will be delivered within 1-3 business days.
The growing awareness of diabetes care is driving the Middle East and Africa industry. With the rising prevalence of chronic diseases, the adoption of healthier lifestyles, and growing government initiatives, raises the demand, resulting in market expansion. For instance, in 2021, the UAE government has set a goal to improve its citizens' overall health and well-being, including reducing the prevalence of chronic diseases like diabetes. The National Agenda for UAE Vision 2021 includes strategies to enhance healthcare services, promote healthy lifestyles, and invest in research and innovation in the healthcare sector. These initiatives aim to reduce the burden of diabetes on the healthcare system and improve patients' overall quality of life.
Middle East & Africa Diabetes Care Devices Market Report Highlights
- Based on type, the insulin delivery devices segment held the largest market share of 54.2% in 2023 and is expected to witness the fastest CAGR from 2024 to 2030. These devices are primarily used by individuals with diabetes who require insulin therapy to regulate their blood sugar. Insulin pens, pumps, needles, and syringes are the most widely used insulin delivery devices.
- Based on the distribution channel, the hospital pharmacies segment accounted for the largest revenue share in 2023. Hospital pharmacies stock various diabetes care devices, including blood glucose monitors, insulin delivery systems, and continuous glucose monitoring (CGM) systems.
- In terms of end-use, the hospital segment held the largest market revenue share in 2023. The hospital segment is expected to continue dominating the market due to the high foot traffic and availability of products, making it easier for patients to obtain diabetes care devices.
- This growth can be attributed to various market drivers, including technological advancements, increasing healthcare expenditure, and growing awareness about diabetes management.
- In October 2022, Nemaura Medical, Inc. received a tentative purchase order from TPMENA, their licensed company for the MENA region, for the sugarBEAT system. Nemaura Medical, Inc. is a medical technology firm dedicated to creating and marketing non-invasive wearable diagnostic devices, including CGM devices, and offering customized lifestyle coaching programs. The sugarBEAT system is an AI-powered CGM device.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Middle East & Africa Diabetes Care Devices Market Variables, Trends & Scope
Chapter 4. Middle East & Africa Diabetes Care Devices Market: Type Estimates & Trend Analysis
Chapter 5. Middle East & Africa Diabetes Care Devices Market: Distribution Channel Estimates & Trend Analysis
Chapter 6. Middle East & Africa Diabetes Care Devices Market: End-use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Abbott
- Dexcom, Inc.
- Medtronic
- F. Hoffmann-La Roche Ltd
- Novo Nordisk A/S
- Ascensia Diabetes Care
- Bionime Corporation
- Agamatrix, Inc.
- Lifescan
- Insulet Corporation
- Lilly
- Sanofi
- Rossmax International Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 158 |
| Published | June 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.03 Billion |
| Forecasted Market Value ( USD | $ 1.79 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Africa, Middle East |
| No. of Companies Mentioned | 13 |
